PRIMA-1MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells

被引:0
|
作者
Kotob, Shadi N. [1 ]
Kelts, Jessica L. [1 ]
机构
[1] Univ Michigan Flint, Dept Nat Sci, Flint, MI 48502 USA
来源
ACS OMEGA | 2023年 / 8卷 / 33期
关键词
MUTANT P53; TUMOR-GROWTH; D-RECEPTOR; IN-VIVO; APR-246; INHIBITION; APOPTOSIS; CALCIUM; EB1089; RISK;
D O I
10.1021/acsomega.3c03719
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Vitamin D is a steroidhormone that causes growth suppression incultured cells. We had previously discovered that the triple-negativebreast cancer cell lines MDA-MB-231 and MDA-MB-468 did not have growthsuppression with vitamin D, while MCF-7 did. MCF-7 cells are not triple-negativeand have wild-type p53. Both MDA-MB-231 and MDA-MB-468 have mutationsin p53 and these mutations were a possible explanation for the lackof growth suppression with vitamin D. Our hypothesis was that reactivationof p53 in the triple-negative cell lines would cause them to becomesensitive to vitamin D. We chose to use the small molecule PRIMA-1(MET) to reactivate p53 as it has been previously shown to restorefunction to the p53 mutants present in MB-231 and MB-468. We thenmeasured the ability of vitamin D and its analogues calcipotriol andEB1089 to suppress growth in the presence of PRIMA-1(MET). Here, we show that while PRIMA-1(MET) can kill the breastcancer cells investigated in this study, it does not restore theirsensitivity to vitamin D or its analogues.
引用
收藏
页码:30500 / 30507
页数:8
相关论文
共 50 条
  • [1] L-Lysine increased the cytotoxicity effect of doxorubicin in MDA-MB-231 and MDA-MB-468 breast cancer cell lines
    Chehri, Javad
    Jahani, Mozhgan
    Tahmasebi, Hadis
    Yarani, Reza
    Mansouri, Kamran
    ANNALS OF ONCOLOGY, 2019, 30 : 127 - 127
  • [2] Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
    Huang, Zhaoming
    Yu, Panpan
    Tang, Jianhui
    ONCOTARGETS AND THERAPY, 2020, 13 : 5395 - 5405
  • [3] The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells
    Katsuya Nakai
    Weiya Xia
    Hsin-Wei Liao
    Mitsue Saito
    Mien-Chie Hung
    Hirohito Yamaguchi
    Breast Cancer, 2018, 25 : 74 - 80
  • [4] The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells
    Nakai, Katsuya
    Xia, Weiya
    Liao, Hsin-Wei
    Saito, Mitsue
    Hung, Mien-Chie
    Yamaguchi, Hirohito
    BREAST CANCER, 2018, 25 (01) : 74 - 80
  • [5] Ectophosphatase activity in the triple-negative breast cancer cell line MDA-MB-231
    Lacerda-Abreu, Marco A.
    Russo-Abrahao, Thais
    Leite Tenorio Aguiar, Raissa
    Monteiro, Robson de Queiroz
    Rumjanek, Franklin D.
    Meyer-Fernandes, Jose R.
    CELL BIOLOGY INTERNATIONAL, 2021, 45 (02) : 411 - 421
  • [6] β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells
    Di Sotto, Antonella
    Gulli, Marco
    Minacori, Marco
    Mancinelli, Romina
    Garzoli, Stefania
    Percaccio, Ester
    Incocciati, Alessio
    Romaniello, Donatella
    Mazzanti, Gabriela
    Eufemi, Margherita
    Di Giacomo, Silvia
    BIOMEDICINES, 2022, 10 (09)
  • [7] Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
    Alsrhani, Abdullah
    Elderdery, Abozer Y.
    Alzahrani, Badr
    Alzerwi, Nasser A. N.
    Althobiti, Maryam Musleh
    Rayzah, Musaed
    Idrees, Bandar
    Elkhalifa, Ahmed M. E.
    Subbiah, Suresh K.
    Mok, Pooi Ling
    MOLECULES, 2023, 28 (07):
  • [8] A preliminary mechanistic exploration of the effect of leptin on the docetaxel sensitivity of MDA-MB-231 triple-negative breast cancer cells
    Gao, Simeng
    Ding, Sijuan
    Tang, Zhaohui
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (03)
  • [9] Liposomal-Naringenin Radiosensitizes Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro
    Pearce, Keenau
    Cairncross, Samantha I.
    Benjeddou, Mongi
    IET NANOBIOTECHNOLOGY, 2024, 2024
  • [10] Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib
    Wang, Xinzhao
    Song, Hongkuan
    Yu, Qian
    Liu, Qi
    Wang, Leilei
    Liu, Zhaoyun
    Yu, Zhiyong
    ONCOLOGY REPORTS, 2015, 33 (02) : 526 - 532